Molecular selection of therapy in metastatic colorectal cancer: the FOCUS4 molecularly stratified RCT

MLA

Louise C Brown, et al. “Molecular Selection of Therapy in Metastatic Colorectal Cancer: The FOCUS4 Molecularly Stratified RCT.” Efficacy and Mechanism Evaluation, vol. 9, Dec. 2022, pp. 1–92. EBSCOhost, https://doi.org/10.3310/htnb6908.

APA

Louise C Brown, David Fisher, Richard Adams, Jenny Seligmann, Matthew Seymour, Richard Kaplan, Susan D Richman, Philip Quirke, Rachel Butler, Helen Roberts, Janet Graham, Richard H Wilson, & Timothy S Maughan. (2022). Molecular selection of therapy in metastatic colorectal cancer: the FOCUS4 molecularly stratified RCT. Efficacy and Mechanism Evaluation, 9, 1–92. https://doi.org/10.3310/htnb6908

Chicago

Louise C Brown, David Fisher, Richard Adams, Jenny Seligmann, Matthew Seymour, Richard Kaplan, Susan D Richman, et al. 2022. “Molecular Selection of Therapy in Metastatic Colorectal Cancer: The FOCUS4 Molecularly Stratified RCT.” Efficacy and Mechanism Evaluation 9 (December): 1–92. doi:10.3310/htnb6908.